Aug 01st 2012 - Edison Investment Research today published a report on Allocate Software (ALL.L, LSE:ALL, LON:ALL) entitled "Delivering The Goods". In summary, the report says:
Allocate has delivered another good year with sales, earnings and cash flow ahead of our forecast. With HealthRoster V10 now launched, a NHS renewal cycle beginning and broadened portfolio giving plenty of scope for cross-selling, the company looks in good shape for 2013 and beyond. The acquisition of RealTime marks a further step beyond workforce optimisation to become a comprehensive supplier of healthcare productivity solutions, a move that the company looks well positioned to make.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »